Enhanced drug transport through alginate biofilms using magnetic nanoparticles

Progress in Biomedical Optics and Imaging - Proceedings of SPIE

Volumn 7189, Issue , 2009, Pages

  McGill, Shayna L ^a   Cuylear, Carla ^a   Smyth, Hugh ^a   Adolphi, Natalie L ^b   Osinski, Marek ^c  

^a UNIVERSITY OF NEW MEXICO   (United States)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

Cystic fibrosis; P. aerguinosa biofilm; Single particle tracking; Superparamagnetic particles

Indexed keywords

ANTIBIOTIC THERAPY; BACTERIAL BIOFILM; BIOFILM MODELS; BULK DIFFUSIONS; CHRONIC INFECTION; CYSTIC FIBROSIS; DRUG TRANSPORT; EXTERNAL MAGNETIC FIELD; IMPLANTABLE MEDICAL DEVICES; IN-VITRO; IN-VIVO; MAGNETIC NANOPARTICLES; NANOPARTICLE SIZES; P. AERGUINOSA BIOFILM; P.AERUGINOSA; SINGLE PARTICLE TRACKING; SUPERPARAMAGNETIC NANOPARTICLES; SUPERPARAMAGNETIC PARTICLES; TRANSPORT RATE;

ALGINATE; BIOFILTERS; MAGNETIC BUBBLES; MAGNETIC FIELDS; NANOPARTICLES; PARTICLE BEAM TRACKING; SEMICONDUCTOR QUANTUM DOTS; SUPERPARAMAGNETISM; SURFACE CHEMISTRY;

BIOFILMS;

EID: 66749115611     PISSN: 16057422     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1117/12.816830     Document Type: Conference Paper

References (23)

1. Smith A.W., Biofilms and antibiotic therapy: Is there a role for combating bacterial resistance by the use of novel drug delivery systems? Advanced Drug Delivery Reviews 57, 1539-1550 (2005)
2. Anderl J.N., Franklin M.J., Stewart P.S. Role of antibiotic penetration limitation in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin. Antimicrob Agents Chemother. 44(7),1818-1824 (2000)
3. Deretic V., M. J. Schurr, J. C. Boucher, and D. W. Martin. Conversion of Pseudomonas aeruginosa to mucoidy in cystic fibrosis: environmental stress and regulation of bacterial virulence by alternative sigma factors. J. Bacteriol. 176, 2773-2780 (1994)
4. Costerton J. W., P. S. Stewart and E. P. Greenberg. Bacterial biofilms: a common cause of persistent infections. Science 284, 1318-1322 (1999)
5. Blaser J., P. Vergeres A. F. Widmer and W. Zimmerli. In vivo verification of in vitro model of antibiotic treatment of device-related infection. Antimicrob. Agents Chemother. 39, 1134-1139 (1995)
6. Darouiche R. O., A. Dhir A. J. Miller G. C. Landon, I. I. Raad, and D. M. Musher. Vancomycin penetration into biofilm covering infected prostheses and effect on bacteria. J. Infect. Dis. 170, 720-723 (1994)
7. Stickler D. J., N. S. Morris, R. J. C. McLean, and C. Fuqua. Biofilms on indwelling urethral catheters produce quorum-sensing signal molecules in situ and in vitro. Appl. Environ. Microbiol. 64, 3486-3490 (1998)
8. Khardori N., and M. Yassien. Biofilms in device-related infections. J. Ind. Microbiol. 15, 141-147 (1995)
9. Jensen E. T., A. Kharazmi, K. Lam, J. W. Costerton, and N. Hoiby. Human polymorphonuclear leukocyte response to Pseudomonas aeruginosa grown in biofilms. Infect. Immun. 58, 2383-2385 (1990)
10. Anwar H., J. L. Strap and J. W. Costerton. Kinetic interaction of biofilm cells of Staphylococcus aureus with cephalexin and tobramycin in a chemostat system. Antimicrob. Agents Chemother. 36, 890-893 (1992)
11. Dunne W. M., Jr., E. O. Mason, and S. L. Kaplan. Diffusion of rifampin and vancomycin through a Staphylococcus epidermidis biofilm. Antimicrob. Agents Chemother. 37, 2522-2526 (1993)
12. Hoyle B. D., J. Alcantara, and J. W. Costerton. Pseudomonas aeruginosa biofilm as a diffusion barrier to piperacillin. Antimicrob. Agents Chemother. 36, 2054-2056 (1992)
13. Berry C. C., and Curtis A. S. G. Functionalisation of magnetic nanoparticles for applications in biomedicine J. Phys. D: Appl. Phys. 36 R198-R206 (2003)
14. Johannsen M., Gneveckow U., Eckelt L., Feussner A., Waldöfner N., Scholz R., Deger S., Wust P., Loening, S.A., Jordan A. Clinical hyperthermia of prostate cancer using magnetic nanoparticles: Presentation of a new interstitial technique, International Journal of Hyperthermia, 21(7), 637-647 (2005)
15. Lubbe A. S., Alexiou C., Bergemann C., Clinical Applications of Magnetic Drug Targeting, Journal of Surgical Research 95, 200-206 (2001)
16. Govan J. R., Deretic V. Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev. 60(3), 539-574 (1996)
17. Hatch R. A., Schiller N. L., Alginate lyase promotes diffusion of aminoglycosides through the extracellular polysaccharide of mucoid Pseudomonas aeruginosa. Antimicrob Agents Chemother. 42(4), 974-977 (1998)
18. McGill S. L., Cuylear C. L., Adolphi N. L., Osinski M., Smyth H. D. C., Magnetically Responsive Nanoparticles for Drug Delivery Applications Using Low Magnetic Field Strengths. IEEE Trans. NanoBioscience, Accepted
19. Sutherland I. W., Exopolysaccharides in biofilms, flocs and related structures, Water Science and Technology, 43(6), 77-86 (2001)
20. Lewis K. "Riddle of biofilm resistance." Antimicrob. Agents Chemother. 45(4), 999-1007 (2001).
21. Walters III, M.C., Roe, F., Bugnicourt, A., Franklin, M.J., and Stewart, P.S. "Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin." Antimicrob. Agents Chemother. 47(1), 317-323 (2003).
22. Dawson M., Wirtz D., and Hanes J. "Enhanced viscoelasticity of human cystic fibrosis sputum correlates with increasing microheterogeneity in particle transport." J. Bio. Chem. 278(50), 50393-50401 (2003).
23. Lai S.K., O'Hanlon D.E., Harrold S., Man S.T., Wang Y., Cone R. and Hanes J. "Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus."